About this EventFree Event
Ketamine as a Novel Antidepressant for Treatment-Resistant Depression in Adolescents
Michael H. Bloch, MD, MS
Associate Professor • Director and Co-Founder, Pediatric Depression Clinic • Co-Director, T32 Postdoctoral Research Fellowship in Childhood Neuropsychiatric Disorders • Associate Program Director, Albert J. Solnit Integrated Training Program • Co-Director, Tic and OCD Program • Child Study Center • Yale School of Medicine
Upon completion of this activity, participants will be able to:
Child and Adolescent Psychiatry and Behavioral Sciences Grand Rounds presentations are for educational purposes and intended only for behavioral/mental health professionals and clinical providers.
Continuing education (CE) credit is available for physicians, psychologists, nurses, and therapists who participate in this activity.